FDAnews Drug Daily Bulletin

SKINMEDICA SETS 5.25 MLN SHARE IPO

Sept. 6, 2005
A A

Specialty pharmaceutical developer SkinMedica Inc. may offer up to 5.25 million shares for between $11 and $13 a share in an initial public offering according to a regulatory filing on Thursday. Underwriters, to be led by SG Cowen & Co., Piper Jaffray, Thomas Weisel Partners LLC and CE Unterberg, Towbin, have the option to buy an additional 787,500 shares to cover over-allotments, according to the filing with the U.S. Securities and Exchange Commission.

Reuters (http://today.reuters.com/investing/financeArticle.aspx?type=governmentFilingsNews&storyID=URI:urn:newsml:reuters.com:20050901:MTFH46972_2005-09-01_21-00-46_WAT003752:1)